萨吉梅生物科学 SGMT
$9.85 +$0.73 (+8.00%)
休市 · Nov 7, 9:10 am ET · 最新盘后价 $9.85 0.00%
开盘$9.25
昨收$9.12
当日区间$9.02 – $9.87
成交量857.9K
市值$698.45M
市盈率（TTM）–
股息率–
基本面
最新报告季度：Q2, ended Jun 2026
营收$0.00
营业利润-$15.82M-32.6% YoY
净利润-$13.95M-34.3% YoY
摊薄每股收益-$0.26+18.8% YoY
自由现金流-$11.10M-22.0% YoY
经营现金流-$11.10M
营收，近8个季度
净利润，近8个季度
各季度摊薄每股收益
各季度自由现金流
年度营收
盈利能力与资产负债表
净资产收益率-24.4%
资产收益率-23.5%
投入资本回报率-27.0%
流动比率45.02
负债/资产比率2.8%
现金及投资$240.13M
总负债$1.86M
净现金（净负债）$238.27M
利润表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 营业总收入 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 营业费用 | $15.82M | $11.71M | $56.89M | $10.77M | $14.33M |
| 销售及管理费用 | $4.28M | $4.72M | $17.84M | $4.03M | $4.60M |
| -管理费用 | $4.28M | $4.72M | $17.84M | $4.03M | $4.60M |
| 研发费用 | $11.54M | $7.00M | $39.05M | $6.73M | $9.73M |
| 营业利润 | -$15.82M | -$11.71M | -$56.89M | -$10.77M | -$14.33M |
| 非经营性利息净收入（支出） | $1.87M | $1.06M | $5.85M | $1.20M | $1.43M |
| 非经营性利息收入 | $1.87M | $1.06M | $5.85M | $1.20M | $1.43M |
| 税前利润 | -$13.95M | -$10.65M | -$51.04M | -$9.57M | -$12.91M |
| 净利润 | -$13.95M | -$10.65M | -$51.04M | -$9.57M | -$12.91M |
| 持续经营利润 | -$13.95M | -$10.65M | -$51.04M | -$9.57M | -$12.91M |
| 归属母公司净利润 | -$13.95M | -$10.65M | -$51.04M | -$9.57M | -$12.91M |
| 归属普通股股东净利润 | -$13.95M | -$10.65M | -$51.04M | -$9.57M | -$12.91M |
| 基本每股收益 | -$0.26 | -$0.33 | -$1.58 | -$0.29 | -$0.40 |
| 摊薄每股收益 | -$0.26 | -$0.33 | -$1.58 | -$0.29 | -$0.40 |
资产负债表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 总资产 | $263.43M | $107.76M | $116.48M | $116.48M | $128.40M |
| 流动资产合计 | $243.99M | $107.72M | $116.40M | $116.40M | $119.48M |
| 现金及现金等价物与短期投资 | $240.13M | $104.54M | $113.12M | $113.12M | $116.69M |
| -现金及现金等价物 | $165.90M | $36.63M | $35.02M | $35.02M | $32.50M |
| -短期投资 | $74.23M | $67.91M | $78.10M | $78.10M | $84.20M |
| 预付资产 | $3.20M | $2.53M | $2.80M | $2.80M | $2.29M |
| 一年内递延资产 | $434,000.00 | $402,000.00 | $282,000.00 | $282,000.00 | $247,000.00 |
| 其他流动资产 | $226,000.00 | $248,000.00 | $199,000.00 | $199,000.00 | $253,000.00 |
| 非流动资产合计 | $19.44M | $39,000.00 | $78,000.00 | $78,000.00 | $8.92M |
| 固定资产净值 | $1.95M | $39,000.00 | $78,000.00 | $78,000.00 | $115,000.00 |
| -固定资产原值 | $1.95M | $39,000.00 | $78,000.00 | $78,000.00 | $115,000.00 |
| 投资及预付款 | $17.44M | – | $0.00 | $0.00 | $8.81M |
| -可供出售证券 | $17.44M | – | – | – | $8.81M |
| 其他非流动资产 | $55,000.00 | – | – | – | – |
| 负债合计 | $7.28M | $5.30M | $5.10M | $5.10M | $9.15M |
| 流动负债合计 | $5.42M | $5.30M | $5.10M | $5.10M | $9.15M |
| 应付款 | $1.13M | $2.30M | $1.31M | $1.31M | $4.24M |
| -应付账款 | $1.13M | $2.30M | $1.31M | $1.31M | $4.24M |
| 一年内应计费用 | $4.18M | $2.94M | $3.69M | $3.69M | $4.78M |
| 短期债务及融资租赁负债 | $84,000.00 | $39,000.00 | $78,000.00 | $78,000.00 | $115,000.00 |
| -一年内到期融资租赁负债 | $84,000.00 | $39,000.00 | $78,000.00 | $78,000.00 | $115,000.00 |
| 其他流动负债 | $26,000.00 | $15,000.00 | $27,000.00 | $27,000.00 | $8,000.00 |
| 非流动负债合计 | $1.86M | $0.00 | $0.00 | $0.00 | $0.00 |
| 长期债务及融资租赁负债 | $1.86M | – | – | – | – |
| -长期融资租赁负债 | $1.86M | – | – | – | – |
| 股东权益合计 | $256.16M | $102.46M | $111.38M | $111.38M | $119.26M |
| 股东权益 | $256.16M | $102.46M | $111.38M | $111.38M | $119.26M |
| 股本 | $6,000.00 | $3,000.00 | $3,000.00 | $3,000.00 | $3,000.00 |
| -普通股 | $6,000.00 | $3,000.00 | $3,000.00 | $3,000.00 | $3,000.00 |
| -优先股 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 资本公积 | $627.18M | $459.45M | $457.61M | $457.61M | $455.92M |
| 留存收益 | -$370.95M | -$357.00M | -$346.35M | -$346.35M | -$336.78M |
| 不影响留存收益的损益 | -$77,000.00 | $8,000.00 | $120,000.00 | $120,000.00 | $117,000.00 |
现金流量表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 经营活动现金流 | -$11.10M | -$8.61M | -$45.65M | -$11.83M | -$10.18M |
| 持续经营经营活动现金流净额 | -$11.10M | -$8.61M | -$45.65M | -$11.83M | -$10.18M |
| 持续经营净利润 | -$13.95M | -$10.65M | -$51.04M | -$9.57M | -$12.91M |
| 其他非现金项目 | $39,000.00 | $39,000.00 | $151,000.00 | $37,000.00 | $37,000.00 |
| 营运资金变动 | -$859,000.00 | $301,000.00 | -$1.05M | -$4.29M | $701,000.00 |
| -预付资产变动 | -$529,000.00 | -$297,000.00 | -$1.83M | -$283,000.00 | -$825,000.00 |
| -应付账款及应计费用变动 | -$236,000.00 | $637,000.00 | $929,000.00 | -$3.97M | $1.56M |
| -其他流动负债变动 | -$39,000.00 | -$39,000.00 | -$152,000.00 | -$37,000.00 | -$37,000.00 |
| 投资活动现金流净额 | -$24.02M | $10.22M | $4.56M | $14.36M | $75,000.00 |
| 持续经营投资活动现金流净额 | -$24.02M | $10.22M | $4.56M | $14.36M | $75,000.00 |
| 投资购置及出售净额 | -$24.02M | $10.22M | $4.56M | $14.36M | $75,000.00 |
| 期末现金余额 | $165.90M | $36.63M | $35.02M | $35.02M | $32.50M |
| 现金净变动 | $129.27M | $1.61M | -$40.82M | $2.53M | -$9.83M |
| 期初现金余额 | $36.63M | $35.02M | $75.84M | $32.50M | $42.33M |
| 自由现金流 | -$11.10M | -$8.61M | -$45.65M | -$11.83M | -$10.18M |
| 筹资活动现金流 | – | – | $275,000.00 | $0.00 | $274,000.00 |
| 持续经营筹资活动现金流净额 | – | – | $275,000.00 | $0.00 | $274,000.00 |
| 普通股发行净额 | – | – | $0.00 | $0.00 | $0.00 |
| 股票期权行使所得 | – | – | $275,000.00 | $0.00 | $274,000.00 |
暂无评论——快来第一个聊聊 SGMT。
登录后参与讨论。